Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
New NIH "FORMS-G" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2022
National Institutes of Health
Agency for Healthcare Research and Quality
Food and Drug Administration
Update: Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements
National Institutes of Health
Agency for Healthcare Research and Quality
Food and Drug Administration
Substance Abuse and Mental Health Services Administration
Department of Veteran's Affairs
General Notices
Pre-application Webinar for RFA-CA-21-048 - Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)
National Cancer Institute
Pre-application Webinar for RFA-CA-21-049 - Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
National Cancer Institute
Pre-Application Webinar for the "PDAC Stromal Reprograming Consortium (PSRC)": RFA-CA-21-041 and RFA-CA-21-042
National Cancer Institute
Notice of NICHD Participation in PAR-21-253 "Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Informational Webinar for Funding Opportunities to Build and Provide Content for a New Educational Resource on the Principles of Rigorous Research
National Institute of Neurological Disorders and Stroke
Extension of COVID Flexibilities for Instruction in the Responsible Conduct of Research
National Institutes of Health
Agency for Healthcare Research and Quality
Guidance on Flexibilities for Conducting Semiannual Inspections of Animal Facilities
Office of the Director, NIH
Adjusted Timeline for Requiring Two-Factor Authentication to Access eRA Modules Using Login.Gov or InCommon Federated Accounts
National Institutes of Health
Technical Assistance Webinar for: Clinical and Translational Science Award (UM1) (PAR-21-293)
National Center for Advancing Translational Sciences
Critical resource gaps and opportunities to support Next Generation Sequencing (NGS) test development, validation, and data interpretation, including through the use of technologies such as artificial intelligence (AI)/machine learning (ML).
Office of the Director, NIH
Food and Drug Administration
Request for Information: Critical resource gaps and opportunities to support radiological tool development and clinical data interpretation using artificial intelligence (AI)/machine learning (ML)
Office of the Director, NIH
Food and Drug Administration
Notice of Changes to Funding Opportunities
Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-21-248 Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
Notice of Change to Research Objectives and Eligibility of Foreign Components for PAR-20-313 - Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Cancer Institute
Notice of Change to Research Objectives and Eligibility of Foreign Components for PAR-20-314 - Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trial Not Allowed)
National Cancer Institute
Notice to Extend the Expiration Date for PAR-19-368, "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)"
National Institute on Drug Abuse
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
Notice to Extend the Expiration Date for PAR-19-162, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)"
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Notice to Extend the Expiration Date for PAR-19-163, "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)"
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Notice of Change to include NIDA-Specific Interest Areas in PAR-21-280, "Dyadic interpersonal processes and biopsychosocial outcomes (R01, Basic Experimental Studies with Humans)"
National Institute on Drug Abuse
Notice of Change to include NIDA-Specific Interest Areas in PAR-21-281, "Dyadic interpersonal processes and biopsychosocial outcomes (R01, Clinical Trials Not Allowed)"
National Institute on Drug Abuse
Notice of Change to Add Responsiveness Criteria and Further Clarify Clinical Trials Allowed in PAR-20-316 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Notice of Change to Add Responsiveness Criteria and Further Clarify Clinical Trials Allowed in PAR-19-040 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Notice of Correction to Key Dates for PAR-21-265 "NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)".
National Institute of Neurological Disorders and Stroke
Notice of Correction to Key Dates for PAR-21-266 "NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)".
National Institute of Neurological Disorders and Stroke
Notice of Correction to Key Dates for PAR-21-267 "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)".
National Institute of Neurological Disorders and Stroke
Notice to Extend Expiration Date and Add a Receipt Date for PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
(NOT-OD-21-168)
Office of Disease Prevention
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Notices of Intent to Publish
Notice of Intent to Publish a Funding Opportunity Announcement for Reissue of Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notices of Special Interest
Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP)
National Cancer Institute
Office of Research on Women's Health
Notice of Special Interest (NOSI): Precision Imaging of Oral Lesions
National Institute of Dental and Craniofacial Research
National Cancer Institute
Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
Funding Opportunities
Implementing and Sustaining Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Equity in Outcomes (R34 Clinical Trial Required )
National Institute of Mental Health
Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional)
National Institute of Mental Health
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required)
National Institute of Mental Health
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required)
National Institute of Mental Health
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
John E. Fogarty International Center
National Cancer Institute
National Eye Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
Brazil Regional Prospective Observational Research in Tuberculosis (RePORT) (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required)
Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional)
National Institute on Drug Abuse
Multi-Disciplinary Collaborations to Understand Mechanisms of Systemic Immune Signaling and Inflammation in ADRD and its Progression (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed)
National Cancer Institute
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)
National Cancer Institute
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase 1: Data Production Research and Development Centers (UM1)(Clinical trials not allowed)
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed)
Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U24 Clinical trials not allowed)
National Human Genome Research Institute
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
National Human Genome Research Institute
National Institute of Biomedical Imaging and Bioengineering
Office of the Director, NIH
Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Leveraging Existing Data Resources for Computational Model and Tool Development to Discover Novel Candidate Mechanisms and Biomarkers for ADRD (R01 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.
